Showing results (11-20 of 38) with videos related to
Sort By:
Pageof 4
Neuroimage. Clinical|March 21, 2020
Automated MRI volumetry as a diagnostic tool for Alzheimer's disease: Validation of icobrain dmHanne Struyfs, Diana Maria Sima, Melissa Wittens, et al.Journal of Alzheimer'S Disease : JAD|August 29, 2016
A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in BelgiumCharisse Somers, Hanne Struyfs, Joery Goossens, et al.Journal of Alzheimer'S Disease : JAD|April 23, 2016
Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter StudyMareike Müller, H Bea Kuiperij, Alexandra A M Versleijen, et al.Journal of Alzheimer'S Disease : JAD|October 8, 2015
Diffusion Kurtosis Imaging: A Possible MRI Biomarker for AD Diagnosis?Hanne Struyfs, Wim Van Hecke, Jelle Veraart, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 19, 2015
A 22-single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Aβ42Kristel Sleegers, Karolien Bettens, Arne De Roeck, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 21, 2015
C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's diseaseAnn De Vos, Dirk Jacobs, Hanne Struyfs, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 25, 2017
Validation of the Semiquantitative Static SUVR Method for <sup>18</sup>F-AV45 PET by Pharmacokinetic Modeling with an Arterial Input FunctionJulie Ottoy, Jeroen Verhaeghe, Ellis Niemantsverdriet, et al.Neuroimage. Clinical|March 31, 2019
Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and <sup>18</sup>F-FDG-PET imagingJulie Ottoy, Ellis Niemantsverdriet, Jeroen Verhaeghe, et al.JAMA Neurology|January 7, 2015
Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob diseaseAline Dorey, Yannick Tholance, Alain Vighetto, et al.Journal of Neurochemistry|January 11, 2016
Validation of soluble amyloid-β precursor protein assays as diagnostic CSF biomarkers for neurodegenerative diseasesLinda J C van Waalwijk van Doorn, Marleen J Koel-Simmelink, Ute Haußmann, et al.Pageof 4